Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05634655

Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors.

Conditions: Pituitary Tumors

Sex: All
Enrollment: 500
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Location: China

Summary

DNA methylation is one of the important ways of protein post-translational modification.Pituitary adenoma (PA) is a benign neuroendocrine tumor that originates from adenohypophysial 45 cells, and accounts for 10%-20% of all primary intracranial tumors. However some PAs can present with high invasiveness and irregular growth, which tend to compresses the optic chiasm and third ventricle, encase the internal carotid artery, and affect hormone secretion from the pituitary gland and hypothalamus. In this study we focus on the mechanism of DNA methylation on the invasiveness of pituitary tumors.

Eligibility Criteria

Inclusion Criteria:1) histologically confirmed PAs, 2) Non-function pituitary adenomasExclusion Criteria:1) Associated with other tumors or serious underlying diseases, 2) the medical records were not complete, or the follow-up data were missing.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05634655). StuddyBuddy aggregates publicly available trial information.